Compumedics Limited · ASX:CMP
Compumedics — Investor Presentation (October 2025)
20 slides from Compumedics's investor presentation, Sep 30, 2025
Slide 1: Corporate Presentation October 2025
Corporate Presentation October 2025 For personal use only
Slide 2: Business Snapshot
Business Snapshot Compumedics (ASX: CMP) is a leading global medical technology company focused on sleep, neurological disorders and ultrasonic brain blood flow monitoring. For personal use only Technology Australia based, Generated $51m of developer/leader in with wholly owned Long track record, Gl
Slide 3: Executive Summary
Executive Summary Delivering Record Revenues and Scalable Growth Across Global Healthcare Markets For personal use only Record Sales Orders Record Sales Revenue EBITDA $63.4M $51.0M $2.9M Up +22% on FY24 Up +2% on FY24, +15% excl MEG Up +9% on FY24 Up +49% on FY23 Up +20% on FY23 Major Contract Wins
Slide 4: Board and Management
Board and Management Experienced, Visionary Leadership Driving Innovation, Growth, and Global Market Expansion For personal use only Strengthened Additional Deep Invested Embedded Executive Team Appointments Operational In Systems Performance Capability 1. Strengthened 2. FY26 plans 3. Deep operatio
Slide 5: FY25 Financial Performance
FY25 Financial Performance For personal use only
Slide 6: FY25 Financial Results
FY25 Financial Results Compumedics is delivering strong growth supported by multiple growth opportunities and disciplined cost control Sales Orders ($M) Sales Revenue ($M) USA Sales Orders ($M) For personal use only Record sales orders FY25 up +22% YoY Record sales revenue FY25 up +3% YoY Record USA
Slide 7: FY25 Financial Performance
FY25 Financial Performance Compumedics produced YoY growth across all major financial metrics in FY25 Financial Performance For personal use only FY25 Highlights: 30 June FYE | $M FY23A FY24A FY25A FY26F • Record Sales Orders: $63.4M, up +22% YoY • Record Revenue: $51.0M, up +3% YoY Sales Orders 42.
Slide 8: Business Model and Revenue Diversification
Business Model and Revenue Diversification Diversified revenue base across multiple geographies and segments Geography Segment For personal use only USA: Sleep & SaaS: • High-end PSG systems + rapidly scaling Somfit SaaS platform • Core growth driver with sleep and neuro acceleration • Clinical-grad
Slide 9: Segment Performance & Outlook
Segment Performance & Outlook For personal use only
Slide 10: Segment Overview & Performance
Segment Overview & Performance Compumedics’ technology is focused on the fast growing, high value sleep diagnostics market and the associated fields of neuro-diagnostics and brain research For personal use only Sleep & SaaS ($M) FY24 FY25 YoY% Neuro Monitoring & Research ($M) FY24 FY25 YoY% Sales Or
Slide 11: Sleep & SaaS
Sleep & SaaS SaaS-Driven Sleep Diagnostics Leadership: High-Growth Momentum, Scalable Model, Global Traction % FY25 Example Products / Solutions Business Growth & Strategic Highlights For personal use only Sales Orders Market Positioning & Opportunity (Not Exhaustive) • Strong growth from installed
Slide 12: Neuro Monitoring & Research
Neuro Monitoring & Research Pioneering Neurotech with Scalable MEG Growth and Global Clinical Traction For personal use only % FY25 Example Products / Solutions Business Sales Orders Growth & Strategic Highlights Market Positioning & Opportunity (Not Exhaustive) • Wireless Okti EEG adoption expandin
Slide 13: Bloodflow & TCD (DWL)
Bloodflow & TCD (DWL) AI-Driven TCD Innovation: Commercial Momentum in a $12B Stroke Market % FY25 Example Products / Solutions For personal use only Business Sales Orders Growth & Strategic Highlights Market Positioning & Opportunity (Not Exhaustive) Bloodflow & TCD (DWL) • FY25 revenue of $4.5M (t
Slide 14: Consumables & Customer Care
Consumables & Customer Care High-Margin Recurring Revenue Powering Platform Stickiness and Scale % FY25 Example Products / Solutions For personal use only Business Sales Orders Growth & Strategic Highlights Market Positioning & Opportunity (Not Exhaustive) Consumables Okti® Child Disposable & Custom
Slide 15: Asset Management
For personal use only Asset Management
Slide 16: Investment Highlights
Asset Management Building a Scalable Global Leader in Sleep, Neuro, and Brain Health Diagnostics 1 Leading provider of sleep and neuro diagnostics For personal use only Investment Highlights Diversified operations across 3 core verticals (sleep diagnostics, neuro diagnostics / • Deeply embedded glob
Slide 17: Growth & Outlook
For personal use only Growth & Outlook
Slide 18: Growth & Outlook
Growth & Outlook 2HFY25 financial performance and record orders and run rate provides a baseline target for FY26 Growth Opportunities FY26 Target For personal use only • Revenue growth of +37% YoY to $70.0M Continued expansion in the USA across all products (e.g. currently ~80% • Sustained EBITDA to
Slide 19: Disclaimer
Disclaimer This presentation has been prepared by Compumedics Limited (CMP). For personal use only While the information in this presentation has been prepared in good faith and with reasonable care, no representation or warranty, express or implied, is made as to the accuracy, adequacy or reliabili
Slide 20: Thank You
For personal use only Thank You